Citation Impact
Citing Papers
Utilizing PROTAC technology to address the on-target platelet toxicity associated with inhibition of BCL-X L
2019
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Degradation of proteins by PROTACs and other strategies
2019
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
2020
Exploring Targeted Degradation Strategy for Oncogenic KRASG12C
2019
Targeting Nuclear Receptors with PROTAC degraders
2019
Genetic interaction networks in cancer cells
2019
The trRosetta server for fast and accurate protein structure prediction
2021 StandoutNobel
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
2021 StandoutNobel
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands
2018
A Genome-wide CRISPR Screen Reveals a Role for the Non-canonical Nucleosome-Remodeling BAF Complex in Foxp3 Expression and Regulatory T Cell Function
2020
A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader
2017
Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML
2018
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Distinct Foxp3 enhancer elements coordinate development, maintenance, and function of regulatory T cells
2021 StandoutNobel
Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
2020
The dTAG system for immediate and target-specific protein degradation
2018
Lysosome-targeting chimaeras for degradation of extracellular proteins
2020 StandoutNatureNobel
Plasticity in binding confers selectivity in ligand-induced protein degradation
2018
Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations
2019
A Structural Model of the Endogenous Human BAF Complex Informs Disease Mechanisms
2020
Merkel cell polyomavirus activates LSD1-mediated blockade of non-canonical BAF to regulate transformation and tumorigenesis
2020
Degradation from the outside in: Targeting extracellular and membrane proteins for degradation through the endolysosomal pathway
2021 StandoutNobel
Transforming targeted cancer therapy with PROTACs: A forward-looking perspective
2021
Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead
2017
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Peptidic degron for IMiD-induced degradation of heterologous proteins
2019 StandoutNobel
Cell-Based Ligand Discovery for the ENL YEATS Domain
2020
Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia
2021 StandoutNobel
Works of David Remillard being referenced
A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation
2018
Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands
2017
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma
2018